109th Congress

P.L. 109-129 - The Stem Cell Therapeutic and Research Act of 2005

On December 20, 2005, the President signed H.R. 2520, the Stem Cell Therapeutic and Research Act of 2005, as Public Law 109-129. The bill does not have a direct impact on NIH. It would require the Secretary of HHS, acting through the Director of HRSA, to establish the C.W. Bill Young Cell Transplantation Program, a network of cord blood banks to facilitate the use of cord blood for transplantation purposes. Cord blood units that are collected, but not appropriate for clinical use, would be required to be made available for peer-reviewed research.